Lee Yuchun 4

Accession 0001209191-23-005234

CIK 0000875320other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 4:18 PM ET

Size

26.9 KB

Accession

0001209191-23-005234

Form 4

Period: 2023-01-25

Director

Transactions

Sale
Common Stock
2023-01-25$314.10/sh−2,621$823,256→ 2,454 total
Exercise/Conversion
Common Stock
2023-01-25$72.14/sh+4,000$288,560→ 5,875 total
Exercise/Conversion
Stock Option (Right to Buy)
2023-01-25−4,000→ 5,429 total
Exercise: $72.14Exp: 2024-05-31→ Common Stock (4,000 underlying)
Sale
Common Stock
2023-01-25$312.80/sh−800$250,240→ 5,075 total
Sale
Common Stock
2023-01-26$315.42/sh−302$95,257→ 5,573 total
Exercise/Conversion
Stock Option (Right to Buy)
2023-01-26−4,000→ 1,429 total
Exercise: $72.14Exp: 2024-05-31→ Common Stock (4,000 underlying)
Sale
Common Stock
2023-01-25$314.95/sh−579$182,356→ 1,875 total
Sale
Common Stock
2023-01-26$317.95/sh−1,000$317,950→ 3,433 total
Exercise/Conversion
Common Stock
2023-01-26$72.14/sh+4,000$288,560→ 5,875 total
Sale
Common Stock
2023-01-26$320.25/sh−400$128,100→ 2,555 total
Sale
Common Stock
2023-01-26$316.82/sh−1,140$361,175→ 4,433 total
Sale
Common Stock
2023-01-26$319.25/sh−478$152,602→ 2,955 total
Sale
Common Stock
2023-01-26$320.94/sh−680$218,239→ 1,875 total

Footnotes (12)

[F1]Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
[F10]Open market sales reported on this line occurred at a weighted average price of $320.25 (range $319.80 to $320.77).
[F11]Open market sales reported on this line occurred at a weighted average price of $320.94 (range $320.89 to $320.99).
[F12]Fully vested.
[F2]Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
[F3]Open market sales reported on this line occurred at a weighted average price of $312.80 (range $312.41 to $313.06).
[F4]Open market sales reported on this line occurred at a weighted average price of $314.10 (range $313.53 to $314.50).
[F5]Open market sales reported on this line occurred at a weighted average price of $314.95 (range $314.58 to $315.14).
[F6]Open market sales reported on this line occurred at a weighted average price of $315.42 (range $315.23 to $315.66).
[F7]Open market sales reported on this line occurred at a weighted average price of $316.82 (range $316.23 to $317.16).
[F8]Open market sales reported on this line occurred at a weighted average price of $317.95 (range $317.43 to $318.35).
[F9]Open market sales reported on this line occurred at a weighted average price of $319.25 (range $318.79 to $319.56).

Documents

1 file

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother